A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020)

Clinical trial NCT05818137 · COMPLETED

Trial details

NCT number: NCT05818137
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension

Start date: 2023-05-10
Primary completion: 2024-03-12
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.